Fulcrum Therapeutics FULC
NASDAQ FULC
$3.67 -0.01 (-0.14%)
As of: Oct 2, 2026 · 2:52 PM EDT

Fulcrum Therapeutics (FULC) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Fulcrum Therapeutics' Depreciation & Amortization (CF) came in at $200,000 for Q2 2026, down 33.3% from $300,000 a year earlier and down 40.8% from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Fulcrum Therapeutics reported Depreciation & Amortization (CF) of $1.2 million, down 19.0% year-over-year; for FY2025, it was $1.4 million, down 12.5% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last four years, with a five-year compound annual growth rate of -10.2% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $1.6 million in FY2024 (-27.3%), $2.2 million in FY2023 (-8.9%), $2.41 million in FY2022 (-4.0%) and $2.52 million in FY2021 (+4.8%).
  • Year-over-year, Depreciation & Amortization (CF) has declined for 13 consecutive quarters, with an average decline of 21.1% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 20.0%), and the weakest in Q2 2024 (a decline of 33.3%).
  • Business Quant data shows FULC's Depreciation & Amortization (CF) at $338,000 (Q1 2026), $357,000 (Q4 2025) and $300,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Fulcrum Therapeutics 282.26 Mn 282.26 Mn - 200,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Mar 31, 2026 338,000.00
Dec 31, 2025 357,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 376,000.00
Sep 30, 2024 400,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 500,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 500,000.00
Jun 30, 2023 600,000.00
Mar 31, 2023 600,000.00
Dec 31, 2022 591,000.00
Sep 30, 2022 600,000.00
Jun 30, 2022 700,000.00
Mar 31, 2022 536,000.00
Dec 31, 2021 615,000.00
Sep 30, 2021 600,000.00
API Access

Fulcrum Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=FULC&period=max&api_key=YOUR_API_KEY